Teva Pharmaceutical drops 16% after 44 states accuse drugmaker of conspiring to hike generic drug prices

Forty-four U.S. states, led Connecticut Attorney General William Tong, claim 20 drug companies, including Teva, "systematically" divided up the market for generic drugs to avoid competing with one another.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.